Filing Details
- Accession Number:
- 0001384101-19-000054
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-08 16:30:25
- Reporting Period:
- 2019-05-06
- Accepted Time:
- 2019-05-08 16:30:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1449535 | M Christopher Hall | 6000 Shoreline Court Suite 300 South San Francisco CA 94080 | President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-06 | 42,748 | $8.86 | 71,462 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-05-06 | 63,746 | $6.45 | 135,208 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-05-06 | 8,506 | $5.98 | 143,714 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-06 | 28,780 | $24.72 | 114,934 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-06 | 86,220 | $25.44 | 28,714 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2019-05-06 | 42,748 | $0.00 | 42,748 | $8.86 |
| Common Stock | Stock Option (right to buy) | Disposition | 2019-05-06 | 63,746 | $0.00 | 63,746 | $6.45 |
| Common Stock | Stock Option (right to buy) | Disposition | 2019-05-06 | 8,506 | $0.00 | 8,506 | $5.98 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 37,252 | 2025-03-01 | No | 4 | M | Direct | |
| 21,254 | 2026-02-28 | No | 4 | M | Direct | |
| 82,688 | 2028-03-01 | No | 4 | M | Direct |
Footnotes
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.
- Represents weighted average sales price. Sale prices for the transactions range from $24.00 to $24.98. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- Represents weighted average sales price. Sale prices for the transactions range from $25.00 to $25.82. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- The option is fully vested.
- The option became exercisable as to 25% of the shares on March 1, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
- The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
Billionaire Hedge Funds
